Screening of People with High Blood Pressure in Moscow Region
Abstract
Aim. To perform an arterial hypertension (HT) screening for assessing the awareness of Moscow Region citizens about high blood pressure (BP) and draw their attention to this important risk factor.
Material and methods. The screening was performed as a part of Standardized International Screening Study "May Measurement Month 2018” in five towns of Moscow Region: Domodedovo, Balashikha, Mytishchi, Solnechnogorsk, Klin. 510 participants (324 females, 186 males) were involved, aged from 18 to 86 years (median age 42 [28;57] years). People over 1 8 years were asked to measure BP levels and fill out a questionnaire: age, gender, height and weight, previous BP measurement date, bad habit (tobacco smoking, alcohol consumption), cardiovascular diseases and type 2 diabetes history, previous high BP levels and antihypertensive drugs taking. Elevated BP was considered systolic BP (SBP) ≥140 mm Hg and/or diastolic BP (DBP) ≥90 mm Hg. Mechanical and automatic tonometers were used.
Results. Increased BP was registered in 24% of participants. High BP levels were more common among men of working age and women older than working age. Increased BP was registered for the first time in 7% of the participants, and half of the participants who had previously taken antihypertensive therapy had increased BP levels. The highest prevalence of elevated BP levels was detected in obese men (55%).
Conclusion. Regular preventive medical examinations have the task of health keeping and timely disease prevention. The continuity in the medical care may reduce the incidence of socially significant diseases.
About the Authors
O. M. DrapkinaRussian Federation
Oxana M. Drapkina – MD, PhD, Professor, Corresponding Member of the Russian Academy of Sciences, Director, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
R. N. Shepel
Russian Federation
Ruslan N. Shepel – MD, Head of Department of Management and Analysis of Medical Care; Researcher, Department of Fundamental and Applied Aspects of Obesity; Assistant Director for Regional Development, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
E. S. Ivanova
Russian Federation
Ekaterina S. Ivanova – MD, PhD, Head of Department of Secondary Prevention of Chronic Non-Communicable Diseases and Federal Health Center, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
E. S. Bulgakova
Russian Federation
Elena S. Bulgakova – MD, Head Assistant, Department of Management and Analysis of Medical Care; Junior Researcher, Department of Fundamental and Applied Aspects of Obesity, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
A. N. Kaburova
Russian Federation
Anastasiya N. Kaburova – MD, Junior Researcher, Department of Fundamental and Applied Aspects of Obesity, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
L. M. Zhamalov
Russian Federation
Linar M. Zhamalov – MD, Head of Telemedicine Technology Development Group, Department of Management and Analysis of Medical Care, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
Yu. D. Shalyagin
Russian Federation
Yuriy D. Shalyagin – Chief of Medical Prevention Department, Clinical Center for Restorative Medicine and Rehabilitation
Klinskaya ul. 2, Moscow, 125414 Russia
A. V. Kutcher
Russian Federation
Anton V. Kutcher – Analyst, Telemedicine Technology Development Group, Department of Management and Analysis of Medical Care, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
S. A. Vernadskiy
Russian Federation
Stanislav A. Vernadskiy – Analyst, Human Resources Policy Analysis Group, Department of Management and Analysis of Medical Care, National Medical Research Center for Preventive Medicine
Petroverigsky per. 10, Moscow, 101990 Russia
References
1. Mills K.T, Bundy J.D., Kelly TN. et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016; 134:441 -50. doi:10.1161/CIRCULATIONAHA.115.018912.
2. Beaney T, Schutte A.E., Tomaszewski M. et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6:736-43. doi:10.1016/S2214-109X(18)30259-6.
3. Boytsov S.A., Balanova Yu.A., Shalnova S.A. et al. Arterial hypertension among individuals of 25-64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. (In Russ.) doi:10.15829/1728-8800-2014-4-4-14.
4. Olsen M.H., Angell S.Y, Asma S. et al. A call to action and a life course strategy to address the global burden of raised blood pressure on current and future generations: The Lancet Commission on hypertension. Lancet. 2016;388:2287-712. doi:10.1016/S0140-6736(16)31134-5.
5. Lu J., Lu Y, Wang X. et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390:2549-58. doi:10.1016/S0140-6736(17)32478-9.
6. May Measurement Month. [cited by Apr 4, 2019] Available from: http://maymeasure.com/wpcon-tent/uploads/2018/02/MMM_A5PromotionalFlyer_PrintReadyENGLISH.pdf.
7. Maurer J., Ramos A. One year routine opportunistic screening for hypertension in formal medical settings and potential improvements in hypertension awareness among older persons in developing countries: evidence from the study on global ageing and adult health (SAGE). Am J Epidemiol. 2015;181 (3);180-4. doi:10.1093/aje/kwu339.
8. Dedov I.I., Shestakova M.V, Vikulova O.K. Epidemiology of diabetes mellitus in the Russian Federation: a clinical and statistical report based on data from the Federal Register of Diabetes Mellitus. Diabetes. 2017;20(1 ):13-41 (In Russ.) doi:10.14341/DM8664.
9. Suntsov Yu.I., Bolotskaya L.L., Rudakova O.G. et al. Prevalence of type 2 diabetes mellitus and its complications among the population of Moscow Region - a cross-sectional epidemiological study Diabetes. 2013;4:6-10 (In Russ.) doi:10.14341/DM201346-10,
10. Dedov I.I., Shestakova M.V, Galstyan G.R. The prevalence of type 2 diabetes in the adult population of Russia (NATION study). Diabetes. 2016;19(2):104-12 (In Russ.) doi:10.14341/DM2004116-17.
For citation:
Drapkina O.M., Shepel R.N., Ivanova E.S., Bulgakova E.S., Kaburova A.N., Zhamalov L.M., Shalyagin Yu.D., Kutcher A.V., Vernadskiy S.A. Screening of People with High Blood Pressure in Moscow Region. Rational Pharmacotherapy in Cardiology. 2019;15(2):209-214. (In Russ.) https://doi.org/10.20996/1819-6446-2019-15-2-209-214